Study confirms benefits of early PET scanning in Alzheimer’s patients

September 26, 2013

Patients with symptoms of Alzheimer’s disease (AD) who are diagnosed early with PET imaging receive medication earlier and have better clinical outcomes, according to interim results from the first study to confirm the benefits of early diagnosis in the neurodegenerative disease.

These early findings from the Metabolic Cerebral Imaging in Incipient Dementia study come less than a week before an expected national Medicare coverage decision on PET scans for patients with signs of cognitive decline. The Centers for Medicare & Medicaid Services (CMS) sponsored the trial, and interim results are being presented Sept. 26 at the Medical Biotech Forum in China.